IMC Chicago’s Neuronetics STIM Stock Holding History

IMC Chicago’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$53.7K	Buy	+41,300	New	+$60.1K	﹤0.01%	6151

Other funds holding STIM

MAM

Madryn Asset Management New York $36.9M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

IMC Chicago's STIM Position: Q2 2026 in Review

IMC Chicago reduced its Neuronetics (STIM) stake by 47% in Q2 2026, selling an estimated $18.5K and leaving 14,566 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6276.

IMC Chicago first reported a position in STIM in Q1 2026 and has held it in 2 quarters since. The position peaked at $39.6K in Q1 2026. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

IMC Chicago held 14,566 shares of Neuronetics worth $18.9K as of Q2 2026.
IMC Chicago sold 12,728 Neuronetics shares in Q2 2026, an estimated $18.5K.
Neuronetics made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #6276 holding.
IMC Chicago first reported a position in Neuronetics in Q1 2026 and has held it in 2 quarters since.
IMC Chicago's Neuronetics position peaked at $39.6K in Q1 2026.
87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.